Effect of high-glucose concentrations on the expression of collagens and fibronectin by fibroblasts in culture

Experimental Gerontology

Volumn 33, Issue 5, 1998, Pages 445-455

  Benazzoug, Y ^a   Borchiellini, C ^b   Labat Robert, J ^a   Robert, L ^a   Kern, P ^b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b CNRS   (France)

Author keywords

Aging; Collagen; Diabetes; Fibroblast; Fibronectin; High glucose

Indexed keywords

COLLAGEN; COLLAGEN TYPE 3; FIBRONECTIN; GLUCOSE; MESSENGER RNA; METHIONINE; PROLINE; PROTEIN;

AGING; ARTICLE; BIOSYNTHESIS; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DIABETES MELLITUS; EXTRACELLULAR MATRIX; FIBROBLAST; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; CELL AGING; CELL SURVIVAL; CELLS, CULTURED; COLLAGEN; DIURETICS, OSMOTIC; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FIBROBLASTS; FIBRONECTINS; GENE EXPRESSION; GLUCOSE; HUMANS; MANNITOL; PROCOLLAGEN; RNA, MESSENGER; TIME FACTORS;

EID: 0032147131     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0531-5565(98)00015-1     Document Type: Article

References (46)

1. Abrass C.K., Peterson C.V., Raugi G.J. Phenotypic expression of collagen types in mesengial matrix of diabetic and nondiabetic rats. Diabetes. 37:1988;1695-1702.
2. Asselot C., Labat-Robert J., Kern P. Heparin fragments regulate collagen phenotype and fibronectin synthesis in the skin of genetically diabetic mice. Biochem. Pharmacol. 38:1989;895-899.
3. Asselot-Chapel C., Combacau L., Labat-Robert J., Kern P. Expression of fibronectin and interstitial collagen genes in smooth muscle cells Modulation by low molecular weight heparin fragments and serum . Biochem. Pharmacol. 49:1995;653-659.
4. Ayo S.H., Radnik R., Garoni J.A., Troyer D.A., Kreisberg J.J. High glucose increases diacyglycerol mass and activates protein kinase C in mesangial cell cultures. Am. J. Physiol. 261:1991;F571-F577.
5. Benazzoug Y., Logeart D., Labat-Robert J., Robert L., Jozefonvcz J., Kern P. Derivatized dextrans modulate collagen synthesis in aortic smooth muscle cells. Biochem. Pharmacol. 49:1995;847-853.
6. Bernard M.P., Chu L., Ramirez F., Eikenberry E., Prockop D.J. Structure of a cDNA for pro alpha2 chain of human type I procollagen. Biochemistry. 22:1983;1139-1145.
7. Boyer B., Kern P., Fourtanier A., Labat-Robert J. Age-dependent variations of the biosynthesis of fibronectin and fibrous collagens in mouse skin. Exp. Gerontol. 26:1991;375-383.
8. Brownlee M. Glycation products and the pathogenesis of diabetic complications. Diabetes Care. 15:1992;1835-1843.
9. Bucala R., Cerami A. Advanced glycosylation Chemistry, biology and implications for diabetes and aging . Adv. Pharmacol. 23:1992;1-34.
10. Chang C.J., Sonensheim G.E. Increased collagen gene expression in vascular smooth muscle cells cultured in serum or isoleucine deprived medium. Matrix. 11:1991;242-252.
11. Charonis A.S., Reger L.A., Dege J.E., Kouzi-Koliakos K., Furcht L.T., Wohlhueter R.M., Tsilibary E.C. Laminin alterations after in vitro nonenzymatic glucosylation. Diabetes. 39:1990;807-814.
12. Chromczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
13. Cohen M.P., Saini R., Klepser H., Vasanthi V.L. Fibronectin binding to glomerular basement membrane is altered in diabetes. Diabetes. 36:1987;758-763.
14. Cosio F.G. Effects of high glucose concentrations on human mesangial cell proliferation. J. Am. Soc. Nephrol. 5:1995;1600-1609.
15. deCrombrugghe B., Karsenty G., Maity S., Vuorio T., Rossi P., Ruteshouser E.C., Mackinney S.H., Lozano G. Transcriptional mechanisms controlling types I and III collagen genes. Ann. NY Acad. Sci. 580:1990;88-96.
16. El Nabout R., Martin M., Remy J., Kern P., Lafuma C. Collagen synthesis and deposition in cultured fibroblasts from subcutaneous radiation-induced fibrosis. Matrix. 9:1989;411-420.
17. Fukui M., Nakamura T., Ebihara I., Shirato I., Tomino Y., Koide H. ECM gene expression and its modulation by insulin in diabetic rats. Diabetes. 41:1992;1520-1527.
18. Kern P., Sebert B., Robert L. Increased type III:type I collagen ratio in diabetic human conjunctival biopsies. Clin. Physiol. Biochem. 4:1985;113-119.
19. Kern P., Asselot C., Labat-Robert J. Modifications of the relative rates of biosynthesis of collagen and fibronectin in diabetes. Ann. NY Acad. Sci. 580:1990;576-578.
20. Kindy M.S., Chang C.J., Sonensheim G.E. Serum deprivation of vascular smooth muscle cells enhances collagen gene expression. J. Biol. Chem. 263:1988;11426-11430.
21. Kohn R.R., Schnider S.L. Collagen changes in aging skin. Balin A.K., Kligman A.M. Aging and the Skin. 1989;120-140 Raven Press, New York.
22. Kornblihtt A., Umezawa K., Vibe-Pedersen K., Baralle F. Primary structure of human fibronectin; Differential splicing may generate at least 10 polypeptides from a single gene. EMBO J. 7:1985;1755-1759.
23. Kreisberg J.L., Garoni J.A., Radnik R., Ayo S.H. High glucose and TGF-beta1 stimulate fibronectin gene expression through a cAMP response element. Kidney Int. 46:1994;1019-1024.
24. Labat-Robert J., Kern P., Robert L. Biomarkers of connective tissue aging Biosynthesis of fibronectin, collagen type III and elastase . Ann. NY Acad. Sci. 673:1992;16-22.
25. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1980;680-685.
26. Light N.D. Estimation of type I and III collagens in whole tissue by quantitation of CNBr peptides on SDS-polyacrylamide gels. Biochim. Biophys. Acta. 702:1982;30-36.
27. Lovell C.R., Smolenski D.A., Duance V.C., Light N.D., Young S., Dyson M. Type I and III collagen content and fiber distribution in normal skin during aging. Br. J. Dermatol. 117:1987;419-428.
28. MacDonald J.A., Kelley D.C. Degradation of fibronectin by human leukocyte elastase. J. Biol. Chem. 255:1980;8848-8858.
29. Maciera-Coelho A. Biology of normal cell proliferation in vitro. Relevance for in vivo aging. VonHan H.P. Interdisciplinary Topics in Gerontology. 1988;1-218 Karger, Basel.
30. Mays P.K., Bishop J.E., Laurent G.L. Age-related changes in the proportion of type I and III collagen. Mech. Aging Dev. 45:1988;203-212.
31. Monnier V.M., Glomb M., Elgawish A., Sell D.R. The mechanism of collagen cross-linking in diabetes A puzzle nearing resolution . Diabetes. 45:1996;S67-S72.
32. Muona P., Peltonen J., Jaakola S., Uitto J. Increased matrix gene expression by glucose in rat neural connective tissue cells in culture. Diabetes. 40:1991;605-611.
33. Nerlich A., Schleicher E. Immunohistochemical localization of extracellular matrix components in human diabetic glomerular lesions. Am. J. Pathol. 139:1991;889-899.
34. Phan Than L., Robert L., Derouette J.C., Labat-Robert J. Increased biosynthesis and processing of fibronectin in fibroblasts from diabetic mice. Proc. Natl. Acad. Sci. USA. 84:1987;1911-1915.
35. Pugliese G., Pricci F., Pugliese F., Mene P., Lenti L., Andreani D., Galli G., Casini A., Bianchi S., Rotella C.M. Mechanisms of glucose-enhanced extracellullar matrix accumulation in rat glomerular mesangial cells. Diabetes. 43:1994;478-490.
36. Rasoamanantena P., Labat-Robert J., Goldstein S. Variations de la biosynthèse et quantification de l'ARNm de la fibronectine humaine au cours du vieillissement cellulaire. C. R. Soc. Biol. 187:1993;238-246.
37. Rasoamanantena P., Thweatt R., Labat-Robert J., Goldstein S. Altered regulation of the fibronectin gene in Werner Syndrome fibroblasts. Exp. Cell. Res. 213:1994;121-127.
38. Reiser K.M., Amigable M.A., Last J.A. Nonenzymatic glycation of type I collagen. J. Biol. Chem. 267:1992;24207-24216.
39. Roth T., Podesta F., Stepp M.A., Boeri D., Lorenzi M. Integrin overexpression induced by high glucose and by human diabetes. Potential pathway to cell dysfunction in diabetic microngiopathy. Proc. Natl. Acad. Sci. USA. 90:1993;9640-9644.
40. Sandberg M., Vuorio E. Localization of type I, II and III collagen mRNAs in developing human skeletal tissues by in situ hybridization. J. Cell. Biol. 104:1987;1077-1084.
41. Spiro M.J., He Q., D'Autilia M.L. Effect of high glucose on formation of extracellular matrix components by cultured rat heart endothelial cells. Diabetologia. 38:1995;430-436.
42. Takeuchi A., Throckmorton D.C., Broden A.P., Yoshizawa N., Rasmussen H., Kashgarian M. Periodic high extracellular glucose enhances production of collagens III and IV by mesangial cells. Am. J. Physiol. 268:1995;F13-F19.
43. Throckmorton D.C., Brogden A.P., Min B., Rasmussen H., Kasgharian M. PDGF and TGF-beta mediate collagen production by mesangial cells exposed to advanced glycosylation end products. Kidney Int. 48:1995;111-117.
44. Tsilibary E.C., Charonis A.S., Reger L.A., Wohlhueter R.M., Furcht L.T. The effect of nonenzymatic glucosylation on of the main noncollagenous NC1 domain to type IV collagen. J. Biol. Chem. 263:1988;4302-4308.
45. Wiestner M., Rohde H., Helle O., Timpl R., Muller P.K. Low rate of procollagen conversion in dermatosparatic sheep fibroblasts is parallel by increased synthesis of type I and type III collagen. EMBO J. 1:1982;513-516.
46. Yoshioka K., Takemura T., Tohda M., Akano N., Miyamoto H., Ooshima A., Maki S. Glomerular localization of type III collagen in human kidney disease. Kidney Int. 35:1989;1203-1211.